These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

891 related articles for article (PubMed ID: 32775050)

  • 1. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
    Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
    PeerJ; 2020; 8():e9530. PubMed ID: 32775050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
    Chen J; Zhou R
    PeerJ; 2021; 9():e10628. PubMed ID: 33520448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
    Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
    Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of immune escape-related genes in lung adenocarcinoma.
    Jia HR; Li WC; Wu L
    Transl Cancer Res; 2024 Jun; 13(6):2647-2661. PubMed ID: 38988926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis and immunotherapy significances of a cancer-associated fibroblasts-related gene signature in lung adenocarcinoma.
    Luo Y; Zhang S; Xie H; Su Q; He S; Lei Z
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(14):51-61. PubMed ID: 38279482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Robust Seven-Gene Signature Associated With Tumor Microenvironment to Predict Survival Outcomes of Patients With Stage III-IV Lung Adenocarcinoma.
    Zhao H; Zhang X; Guo L; Shi S; Lu C
    Front Genet; 2021; 12():684281. PubMed ID: 34552612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of CCR2 as an immune indicator in lung adenocarcinoma: A study based on tumor-infiltrating immune cell analysis.
    Wan Y; Wang X; Liu T; Fan T; Zhang Z; Wang B; Zhang B; Tian Z; Mao T; Gong Z; Zhang L
    Cancer Med; 2021 Jun; 10(12):4150-4163. PubMed ID: 33949150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.
    Zhu N; Yang Y; Wang H; Tang P; Zhang H; Sun H; Gong L; Yu Z
    Front Oncol; 2022; 12():822849. PubMed ID: 35574409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic Hub Genes in the Immune Microenvironment of Lung Adenocarcinoma by Estimation.
    Liu S; Tian W; Li B
    Comb Chem High Throughput Screen; 2022; 25(1):77-89. PubMed ID: 33308118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a Five Autophagy Subtype-Related Gene Expression Pattern for Improving the Prognosis of Lung Adenocarcinoma.
    Zhang MY; Huo C; Liu JY; Shi ZE; Zhang WD; Qu JJ; Yue YL; Qu YQ
    Front Cell Dev Biol; 2021; 9():756911. PubMed ID: 34869345
    [No Abstract]   [Full Text] [Related]  

  • 11. Identification of novel gene signature for lung adenocarcinoma by machine learning to predict immunotherapy and prognosis.
    Shu J; Jiang J; Zhao G
    Front Immunol; 2023; 14():1177847. PubMed ID: 37583701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
    Niu W; Jiang L
    Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
    Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
    Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma.
    Wu D; Liu Y; Liu J; Ma L; Tong X
    Sci Rep; 2024 Jul; 14(1):17460. PubMed ID: 39075165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of pyroptosis-related factors in lung adenocarcinoma.
    Lin X; Zhou T; Hu S; Yang L; Yang Z; Pang H; Zhou X; Zhong R; Fang X; Yu Z; Hu K
    J Thorac Dis; 2022 Mar; 14(3):654-667. PubMed ID: 35399245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioinformatics analysis of an immunotherapy responsiveness-related gene signature in predicting lung adenocarcinoma prognosis.
    Jiang Y; Hammad B; Huang H; Zhang C; Xiao B; Liu L; Liu Q; Liang H; Zhao Z; Gao Y
    Transl Lung Cancer Res; 2024 Jun; 13(6):1277-1295. PubMed ID: 38973963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR2 and PTPRC are regulators of tumor microenvironment and potential prognostic biomarkers of lung adenocarcinoma.
    Wei J; Fang D; Zhou W
    Ann Transl Med; 2021 Sep; 9(18):1419. PubMed ID: 34733971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC.
    Zhang Q; Zhao M; Lin S; Han Q; Ye H; Peng F; Li L
    Heliyon; 2023 Aug; 9(8):e18503. PubMed ID: 37534013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune microenvironment and regulatory network analysis in patients with lung adenocarcinoma.
    Liu L; Xu S; Huang L; He J; Liu G; Ma S; Weng Y; Huang S
    Transl Cancer Res; 2021 Jun; 10(6):2859-2872. PubMed ID: 35116596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.